Literature DB >> 10905594

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

G Maio1, P d'Argenio, T Stroffolini, A Bozza, L Sacco, M E Tosti, M Intorcia, E Fossi, G d'Alessio, L A Kondili, M Rapicetta, A Mele.   

Abstract

BACKGROUND/AIM: The aim of the study was to estimate the prevalence, risk factors and genotype distribution of hepatitis C virus (HCV) in the general population older than 5 years of age in a southern Italian town. The positive predictive value of alanine transaminase (ALT) screening in identifying HCV positive subjects was also assessed.
METHODS: Cluster random sampling from the census of the general population was used. ELISA and RIBA tests assessed the presence of anti-HCV; nested reverse transcription polymerase chain reaction (RT-PCR) was used to identify HCV-RNA; genotyping was performed by INNO-LIPA III. The association linking anti-HCV seropositivity with potential risk factors was assessed by multiple logistic regression analysis.
RESULTS: Among the 488 subjects enrolled, 79 (16.2%) were anti-HCV positive. The prevalence increased from 1.2% in subjects 6-29 years of age to 42.1% in those > or = 60 years. Forty percent of these positive subjects also had abnormal ALT level and 54.4% were HCV RNA positive by PCR. The positive predictive value of the ALT test in identifying anti-HCV positive subjects was 65%; however, it was 46.7% in subjects younger than 60 years of age and 90.5% in those 60 or older. Genotype 1b was detected in 74% of subjects, type 2c in 23.3%, and type 1a in 2.3%. The only two variables significantly associated with HCV seropositivity in multivariate analysis were age older than 45 years (O.R. 8.5; CI 95%=3.0-24.1) and past use of glass syringes (O.R. 3.4; CI 95%=1.5-7.6).
CONCLUSIONS: These findings confirm that HCV infection is endemic in southern Italy, particularly among the elderly. Percutaneous exposure, such as injections with nondisposable, multiple-use, glass syringes used in the past for medical purposes may have played a major role in the spread of HCV infection. ALT screening is not useful in detecting HCV positive subjects in the general population, particularly among subjects who could benefit from antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905594     DOI: 10.1016/s0168-8278(00)80167-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

1.  In search of the correct strategy for preventing the spread of HCV infection.

Authors:  M Montella; A Crispo; J Wynn-Bellezza
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  High seroprevalence of HCV in the Abruzzo Region, Italy: results on a large sample from opt-out pre-surgical screening.

Authors:  Ennio Polilli; Monica Tontodonati; Maria Elena Flacco; Tamara Ursini; Palmira Striani; Dante Di Giammartino; Maurizio Paoloni; Luigi Vallarola; Gabriella Lucidi Pressanti; Giorgia Fragassi; Patrizia Accorsi; Lamberto Manzoli; Giustino Parruti
Journal:  Infection       Date:  2015-09-12       Impact factor: 3.553

3.  Hepatitis C virus clearance and gender.

Authors:  T Stroffolini; M Rapicetta; R Di Stefano
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

4.  Clinical course of infection with hepatitis C.

Authors:  Sandro Vento; Valerio Nobili; Francesca Cainelli
Journal:  BMJ       Date:  2006-02-18

5.  Recommendations on hepatitis C screening for adults.

Authors:  Roland Grad; Brett Thombs; Marcello Tonelli; Maria Bacchus; Richard Birtwhistle; Scott Klarenbach; Harminder Singh; Veronique Dorais; Nathalie Holmes; Wendy Martin; Rachel Rodin; Alejandra Jaramillo Garcia
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

6.  Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.

Authors:  Yi-Ping Li; Santseharay Ramirez; Sanne B Jensen; Robert H Purcell; Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

7.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

8.  Hypertransaminasemia in childhood as a marker of genetic liver disorders.

Authors:  Raffaele Iorio; Angela Sepe; Antonietta Giannattasio; Francesco Cirillo; Angela Vegnente
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

Review 9.  Hepatitis C: a review for primary care physicians.

Authors:  Tom Wong; Samuel S Lee
Journal:  CMAJ       Date:  2006-02-28       Impact factor: 8.262

10.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.